Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients
about
Peptide-Based Treatment: A Promising Cancer TherapyTrial Watch: Peptide-based anticancer vaccines.The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancerImmunotherapeutic interventions of Triple Negative Breast Cancer.
P2860
Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Feasibility study of personali ...... egative breast cancer patients
@ast
Feasibility study of personali ...... egative breast cancer patients
@en
Feasibility study of personali ...... egative breast cancer patients
@nl
type
label
Feasibility study of personali ...... egative breast cancer patients
@ast
Feasibility study of personali ...... egative breast cancer patients
@en
Feasibility study of personali ...... egative breast cancer patients
@nl
prefLabel
Feasibility study of personali ...... egative breast cancer patients
@ast
Feasibility study of personali ...... egative breast cancer patients
@en
Feasibility study of personali ...... egative breast cancer patients
@nl
P2093
P2860
P356
P1476
Feasibility study of personali ...... egative breast cancer patients
@en
P2093
Akihiko Kawahara
Akira Yamada
Hiroko Otsuka
Kyogo Itoh
Masayoshi Kage
Miki Takenaka
Mina Furukawa
Naoko Seki
Nobutaka Iwakuma
Ryuji Takahashi
P2860
P2888
P356
10.1186/BCR3685
P50
P577
2014-07-03T00:00:00Z
P5875
P6179
1000760496